Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells
Authors
Keywords
Cell cycle analysis, Decitabine, Drug delivery, Nanoparticles, Polymers, Voronistat
Journal
Drug Delivery and Translational Research
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-27
DOI
10.1007/s13346-018-0556-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting triple negative breast cancer with histone deacetylase inhibitors
- (2017) Palma Fedele et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Epigenetics in cancer: Fundamentals and Beyond
- (2017) Subhankar Biswas et al. PHARMACOLOGY & THERAPEUTICS
- Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
- (2017) Huw Geraint Jones et al. WORLD JOURNAL OF SURGERY
- Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
- (2016) Anna Kazanets et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
- (2015) Xiao-xiao Sun et al. ACTA PHARMACOLOGICA SINICA
- Sustained Epigenetic Drug Delivery Depletes Cholesterol–Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids
- (2015) Vijay Raghavan et al. LANGMUIR
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
- (2014) Hariharan Easwaran et al. MOLECULAR CELL
- Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion
- (2013) Sivakumar Vijayaraghavalu et al. CANCER LETTERS
- The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance
- (2013) O. Lavi et al. CANCER RESEARCH
- Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of p21 Gene Expression Leading to G2/M Cycle Arrest
- (2012) Sivakumar Vijayaraghavalu et al. MOLECULAR PHARMACEUTICS
- Epigenetic Modulation of the Biophysical Properties of Drug-Resistant Cell Lipids to Restore Drug Transport and Endocytic Functions
- (2012) Sivakumar Vijayaraghavalu et al. MOLECULAR PHARMACEUTICS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- A pharmacogenetic study of vorinostat glucuronidation
- (2010) Soonmo Peter Kang et al. Pharmacogenetics and Genomics
- High-Definition DNA Methylation Profiles from Breast and Ovarian Carcinoma Cell Lines with Differing Doxorubicin Resistance
- (2010) Michael Boettcher et al. PLoS One
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- Chemical Decomposition of 5-Aza-2′-deoxycytidine (Decitabine): Kinetic Analyses and Identification of Products by NMR, HPLC, and Mass Spectrometry
- (2009) Daniel K. Rogstad et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes
- (2008) A M Calcagno et al. BRITISH JOURNAL OF CANCER
- Evolution of decitabine development
- (2008) Elias Jabbour et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation